GARDASIL™ Vaccine Impact in Population Study (V501-033)

Clinical trial NCT01077856 · COMPLETED

Trial details

NCT number: NCT01077856
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Human Papillomavirus Infections

Start date: 2007-05-29
Primary completion: 2014-12-02
Enrollment: 54516

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.